MARKET

MRSN

MRSN

Mersana
NASDAQ

Real-time Quotes | Nasdaq Last Sale

22.06
-2.17
-8.96%
After Hours: 22.02 -0.04 -0.18% 19:56 09/18 EDT
OPEN
24.71
PREV CLOSE
24.23
HIGH
24.71
LOW
20.76
VOLUME
5.29M
TURNOVER
--
52 WEEK HIGH
26.64
52 WEEK LOW
1.320
MARKET CAP
1.51B
P/E (TTM)
-16.1210
1D
5D
1M
3M
1Y
5Y
News
Financial
Releases
Corp Actions
Analysis
Profile

Analyst Price Target

The average MRSN stock price target is 29.00 with a high estimate of 34.00 and a low estimate of 25.00.

Access Level 2 Advance
Nasdaq TotalView
for Free
Get Now
About MRSN
Mersana Therapeutics, Inc. is a biotechnology company. The Company is focused on discovering and developing a pipeline of antibody drug conjugates (ADCs). The Company focuses on advancing a pipeline of targeted oncology therapeutics leveraging its Fleximer immunoconjugate technology. The Fleximer platform allows it to design ADCs with specific properties and manage the drug's chances of attacking cancers. Its product candidates include XMT-1522 and XMT-1536. The ADC therapies treat cancer patients by engineering a drug conjugate with various anti-cancer agents and controlling when, where and how those agents are released. Dolaflexin is its Fleximer antibody drug conjugation platform, which pairs the Fleximer polymer with its linker chemistries to create ADC therapies.
More
Hot Stocks
Symbol
Price
%Change

Webull offers kinds of Mersana Therapeutics Inc stock information, including NASDAQ:MRSN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, MRSN stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading MRSN stock methods without spending real money on the virtual paper trading platform.